Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GMRS · against 479 other Healthcare companies of similar size
Ranked #142 of 480 · scores higher than 69% of peers
Bars: peers in each 10-point band of the profitability score52 peers with a profitability score of 60–69, including GMRS · Click a bar to see the companies
Mainly thanks to its operating margin, which is stronger than most Healthcare peers.
| Metric | GMRS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 454 reported | 5.5% | 2.6% | 61% | 33% | |
| Operating marginHigher is better · 451 reported | 14.4% | 5.0% | 79% | 33% | |
| Return on assetsHigher is better · 474 reported | Not reported | 1.1% | — | — | 33% |
| Return on equityHigher is better · 454 reported | Not reported | 1.6% | — | — | Context only |
| Gross marginHigher is better · 496 reported | 36.1% | 42.8% | 42% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 578M USD | 99 | 73 | |
| 2 | 914M USD | 99 | 81 | |
| 142 | 3.7B CNY (≈$524M) | 61 | 54 | |
| 142 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 114.7B JPY (≈$780M) |
| 61 |
| 72 |
| 142 | 110.9B JPY (≈$754M) | 61 | 59 |
| 142 | 1.5B SGD (≈$1.1B) | 61 | 60 |
| 142 | 615M USD | 61 | 48 |
| 142 | 862M AUD (≈$569M) | 61 | 54 |
| 149 | 534.0B KRW (≈$385M) | 60 | 59 |
| 149 | 7.9B CNY (≈$1.1B) | 60 | 65 |
| 149 | 3.9B CNY (≈$549M) | 60 | 61 |